Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Dietary Supplements

OSSOS-SANS Tablets Recalled for Undeclared Diclofenac and Methocarbamol

Agency Publication Date: June 17, 2024
Share:
Sign in to monitor this recall

Summary

MexHealth LLC is recalling approximately 20 bottles of OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets after FDA laboratory analysis found the product contains undeclared prescription drugs. The tablets were found to contain diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and methocarbamol, a muscle relaxant, which are not listed on the label. These products were sold in 30-count bottles and distributed nationwide.

Risk

Undeclared diclofenac and methocarbamol can cause serious health risks including gastrointestinal bleeding, cardiovascular issues, and dangerous drug interactions. Consumers taking these tablets may be unknowingly consuming potent prescription medications that can be harmful when combined with other drugs or certain medical conditions.

What You Should Do

  1. The recalled product is OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets, packaged in a 30-count bottle (Lot Number H29585, with no expiration date printed on the bottle).
  2. If you have health concerns regarding the use of this product, contact your healthcare provider or pharmacist immediately.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact MexHealth LLC for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets (30-count)
Variants: 30-count bottle
Lot Numbers:
H29585 (No Expiration date)

Distributed by Naturistas Especializados, Alce Blanco 180-A Fracc. Industrial, Edo. de Mexico C.P. 53370

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94714
Status: Active
Manufacturer: MexHealth LLC
Sold By: Naturistas Especializados
Manufactured In: United States
Units Affected: 20 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.